Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
Mona Bafadhel, Lisa Davies, Peter M.A. Calverley, Shawn D. Aaron, Christopher E. Brightling, Ian D. Pavord
European Respiratory Journal 2014 44: 789-791; DOI: 10.1183/09031936.00062614
Mona Bafadhel
1Dept of Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, Oxford, UK
Lisa Davies
2Aintree Chest Centre, University Hospital Aintree, Liverpool, UK
Peter M.A. Calverley
2Aintree Chest Centre, University Hospital Aintree, Liverpool, UK
3Institute of Ageing and Chronic Diseases, University of Liverpool, Liverpool, UK
Shawn D. Aaron
4Dept of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada
Christopher E. Brightling
5Institute for Lung Health, NIHR Respiratory Biomedical Research Unit, University of Leicester, Leicester, UK
Ian D. Pavord
1Dept of Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, Oxford, UK
Vol 44 Issue 3
Table of Contents
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
Mona Bafadhel, Lisa Davies, Peter M.A. Calverley, Shawn D. Aaron, Christopher E. Brightling, Ian D. Pavord
European Respiratory Journal Sep 2014, 44 (3) 789-791; DOI: 10.1183/09031936.00062614